No headlines found.
Globe Newswire (Tue, 13-Jan 7:45 AM ET)
Fortress Biotech and Cyprium Therapeutics Announce FDA Acceptance of CUTX-101 NDA Resubmission
Globe Newswire (Mon, 15-Dec 8:00 AM ET)
Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Globe Newswire (Fri, 14-Nov 8:30 AM ET)
Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock trades on the NASDAQ stock market under the symbol FBIOP.
As of January 23, 2026, FBIOP stock price climbed to $12.70 with 27,280 million shares trading.
FBIOP has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, FBIOP traded as high as $20.35 and as low as $4.72.
FBIOP has outperformed the market in the last year with a price return of +81.5% while the SPY ETF gained +14.2%. FBIOP has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +88.2% and +23.2%, respectively, while the SPY returned +2.9% and -0.7%, respectively.
FBIOP support price is $11.99 and resistance is $13.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FBIOP shares will trade within this expected range on the day.
